Successful canakinumab treatment identifies IL-1beta as a pivotal mediator in Schnitzler syndrome.

Schnitzler's syndrome presenting as fever of unknown origin (FUO): The role of cytokines in its systemic features

Kleijn, E.M.H.A. de
Telgt, D.
Laan, R.

January 1997

Contains fulltext : 24855___.PDF (publisher's version ) (Open Access

The Schnitzler syndrome

Lipsker Dan

December 2010

Abstract The Schnitzler syndrome is a rare and underdiagnosed entity which is considered today as be...

CONCISE REPORT Beneficial response to anakinra and thalidomide in Schnitzler’s syndrome

H D De Koning
E J Bodar
A Simon
M G Netea

October 2016

Background: Schnitzler’s syndrome is an inflammatory disorder characterised by chronic urticarial ra...

IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.

Ryan, J.G.
Koning, H.D. de
Beck, L.A.
Booty, M.G.
Kastner, D.L.
Simon, A.

January 2008

Contains fulltext : 69910.pdf (publisher's version ) (Closed access

Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature review

Betrains, A
Staels, F
Vanderschueren, S

August 2020

BACKGROUND: Schnitzler syndrome is a rare autoinflammatory disorder characterized by chronic urticar...

Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome

Koning, H.D. de
Schalkwijk, J.
Ven-Jongekrijg, J. van der
Stoffels, M.
Meer, J.W.M. van der
Simon, A.

January 2013

OBJECTIVES: Schnitzler's syndrome is a chronic disabling autoinflammatory disorder, characterised by...

Beneficial response to anakinra and thalidomide in Schnitzler's syndrome.

Koning, H.D. de
Bodar, E.J.
Simon, A.
Hilst, J.C.H. van der
Netea, M.G.
Meer, J.W.M. van der

January 2006

Contains fulltext : 50894.pdf (publisher's version ) (Closed access)BACKGROUND: Sc...

The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome

Koning, H.D. de
Schalkwijk, J.
Stoffels, M.
Jongekrijg, J.
Jacobs, J.F.M.
Verwiel, E.T.P.
Koenen, H.J.P.M.
Preijers, F.W.
Holzinger, D.
Joosten, I.
Meer, J.W.M. van der
Simon, A.

January 2015

INTRODUCTION: Schnitzler's syndrome (SchS) is a disabling autoinflammatory disorder, characterized b...

Increasing the Interval of Canakinumab Administration Effectively Supports the Remission of Schnitzler’s Syndrome

Vadim R. Gorodetskiy
Svetlana O. Salugina
Evgeny S. Fedorov

January 2018

Schnitzler’s syndrome (SchS) is a rare, disabling, autoinflammatory disorder characterized by recurr...

Retention rate of IL-1 inhibitors in Schnitzler's syndrome

Crisafulli F
Vitale A
Airò P
Grigis M
Gaggiano C
Dagna L
Cavalli G
Cimaz R
Viapiana O
Iannone F
Lopalco G
Bortolotti R
Abdel Jaber M
Montecucco C
Monti S
Balduzzi S
Emmi G
Mattioli I
Franceschini F
Cantarini L
Frassi M.

January 2022

Objectives: Schnitzler's syndrome is a rare autoinflammatory disease. Clinical response to IL-1 inhi...

Molecular genetic investigation, clinical features and response to treatment in 21 patients with Schnitzler's syndrome

Rowczenio, DM
Pathak, S
Arostegui, JI
Mensa-Vilaro, A
Omoyinmi, E
Brogan, P
Lipsker, D
Scambler, T
Owen, R
Trojer, H
Baginska, A
Gillmore, JD
Wechalekar, AD
Lane, T
Williams, R
Youngstein, T
Hawkins, PN
Savic, S
Lachmann, HJ

March 2018

To date, the pathogenic mechanisms underlying Schnitzler syndrome remain obscure, in particular, the...

Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th Suppression

Masson Regnault, Marie
Frouin, Eric
Jéru, Isabelle
Delwail, Adriana
Charreau, Sandrine
Barbarot, Sébastien
Néel, Antoine
Masseau, Agathe
Puéchal, Xavier
Kyndt, Xavier
Gayet, Stephane
Lifermann, François
Asli, Bouchra
Balguerie, Xavier
Blanchard-Delaunay, Claire
Aubin, François
Rizzi, Rita
Rongioletti, Franco
Boyé, Thierry
Gusdorf, Laurence
Bessis, Didier
Morel, Franck
Hainaut, Ewa
Lipsker, Dan
Lecron, Jean-Claude

November 2020

International audienceBackgroundSchnitzler syndrome (SchS) is a rare autoinflammatory disease charac...

The Schnitzler syndrome.

Lipsker, Dan

January 2010

International audienceThe Schnitzler syndrome is a rare and underdiagnosed entity which is considere...

Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome

Migliorini P
Italiani P
Pratesi F
Puxeddu I
Boraschi D

January 2019

OBJECTIVES: Schnitzler syndrome (SchS) is an autoinflammatory disorder characterized by chronic urti...

Interleukine-1-remming in cryopyrinegeassocieerd periodiek syndroom (CAPS) en schnitzlersyndroom

de Koning, H.D.
Schalkwijk, J.
Meer, J.W.M. van der
Simon, A.

January 2012

Item does not contain fulltextCryopyrin-associated periodic syndrome (CAPS) is a hereditary autoinfl...

Schnitzler's syndrome presenting as fever of unknown origin (FUO): The role of cytokines in its systemic features

Kleijn, E.M.H.A. de
Telgt, D.
Laan, R.

January 1997

Contains fulltext : 24855___.PDF (publisher's version ) (Open Access

The Schnitzler syndrome

Lipsker Dan

December 2010

Abstract The Schnitzler syndrome is a rare and underdiagnosed entity which is considered today as be...

CONCISE REPORT Beneficial response to anakinra and thalidomide in Schnitzler’s syndrome

H D De Koning
E J Bodar
A Simon
M G Netea

October 2016

Background: Schnitzler’s syndrome is an inflammatory disorder characterised by chronic urticarial ra...

IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.

Ryan, J.G.
Koning, H.D. de
Beck, L.A.
Booty, M.G.
Kastner, D.L.
Simon, A.

January 2008

Contains fulltext : 69910.pdf (publisher's version ) (Closed access

Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature review

Betrains, A
Staels, F
Vanderschueren, S

August 2020

BACKGROUND: Schnitzler syndrome is a rare autoinflammatory disorder characterized by chronic urticar...

Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome

Koning, H.D. de
Schalkwijk, J.
Ven-Jongekrijg, J. van der
Stoffels, M.
Meer, J.W.M. van der
Simon, A.

January 2013

OBJECTIVES: Schnitzler's syndrome is a chronic disabling autoinflammatory disorder, characterised by...

Beneficial response to anakinra and thalidomide in Schnitzler's syndrome.

Koning, H.D. de
Bodar, E.J.
Simon, A.
Hilst, J.C.H. van der
Netea, M.G.
Meer, J.W.M. van der

January 2006

Contains fulltext : 50894.pdf (publisher's version ) (Closed access)BACKGROUND: Sc...

The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome

Koning, H.D. de
Schalkwijk, J.
Stoffels, M.
Jongekrijg, J.
Jacobs, J.F.M.
Verwiel, E.T.P.
Koenen, H.J.P.M.
Preijers, F.W.
Holzinger, D.
Joosten, I.
Meer, J.W.M. van der
Simon, A.

January 2015

INTRODUCTION: Schnitzler's syndrome (SchS) is a disabling autoinflammatory disorder, characterized b...

Increasing the Interval of Canakinumab Administration Effectively Supports the Remission of Schnitzler’s Syndrome

Vadim R. Gorodetskiy
Svetlana O. Salugina
Evgeny S. Fedorov

January 2018

Schnitzler’s syndrome (SchS) is a rare, disabling, autoinflammatory disorder characterized by recurr...

Retention rate of IL-1 inhibitors in Schnitzler's syndrome

Crisafulli F
Vitale A
Airò P
Grigis M
Gaggiano C
Dagna L
Cavalli G
Cimaz R
Viapiana O
Iannone F
Lopalco G
Bortolotti R
Abdel Jaber M
Montecucco C
Monti S
Balduzzi S
Emmi G
Mattioli I
Franceschini F
Cantarini L
Frassi M.

January 2022

Objectives: Schnitzler's syndrome is a rare autoinflammatory disease. Clinical response to IL-1 inhi...

Molecular genetic investigation, clinical features and response to treatment in 21 patients with Schnitzler's syndrome

Rowczenio, DM
Pathak, S
Arostegui, JI
Mensa-Vilaro, A
Omoyinmi, E
Brogan, P
Lipsker, D
Scambler, T
Owen, R
Trojer, H
Baginska, A
Gillmore, JD
Wechalekar, AD
Lane, T
Williams, R
Youngstein, T
Hawkins, PN
Savic, S
Lachmann, HJ

March 2018

To date, the pathogenic mechanisms underlying Schnitzler syndrome remain obscure, in particular, the...

Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th Suppression

Masson Regnault, Marie
Frouin, Eric
Jéru, Isabelle
Delwail, Adriana
Charreau, Sandrine
Barbarot, Sébastien
Néel, Antoine
Masseau, Agathe
Puéchal, Xavier
Kyndt, Xavier
Gayet, Stephane
Lifermann, François
Asli, Bouchra
Balguerie, Xavier
Blanchard-Delaunay, Claire
Aubin, François
Rizzi, Rita
Rongioletti, Franco
Boyé, Thierry
Gusdorf, Laurence
Bessis, Didier
Morel, Franck
Hainaut, Ewa
Lipsker, Dan
Lecron, Jean-Claude

November 2020

International audienceBackgroundSchnitzler syndrome (SchS) is a rare autoinflammatory disease charac...

The Schnitzler syndrome.

Lipsker, Dan

January 2010

International audienceThe Schnitzler syndrome is a rare and underdiagnosed entity which is considere...

Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome

Migliorini P
Italiani P
Pratesi F
Puxeddu I
Boraschi D

January 2019

OBJECTIVES: Schnitzler syndrome (SchS) is an autoinflammatory disorder characterized by chronic urti...

Interleukine-1-remming in cryopyrinegeassocieerd periodiek syndroom (CAPS) en schnitzlersyndroom

de Koning, H.D.
Schalkwijk, J.
Meer, J.W.M. van der
Simon, A.

January 2012

Item does not contain fulltextCryopyrin-associated periodic syndrome (CAPS) is a hereditary autoinfl...

Schnitzler's syndrome presenting as fever of unknown origin (FUO): The role of cytokines in its systemic features

Kleijn, E.M.H.A. de
Telgt, D.
Laan, R.

January 1997

Contains fulltext : 24855___.PDF (publisher's version ) (Open Access

The Schnitzler syndrome

Lipsker Dan

December 2010

Abstract The Schnitzler syndrome is a rare and underdiagnosed entity which is considered today as be...

CONCISE REPORT Beneficial response to anakinra and thalidomide in Schnitzler’s syndrome

H D De Koning
E J Bodar
A Simon
M G Netea

October 2016

Background: Schnitzler’s syndrome is an inflammatory disorder characterised by chronic urticarial ra...

Successful canakinumab treatment identifies IL-1beta as a pivotal mediator in Schnitzler syndrome.

Abstract

Extracted data

Successful canakinumab treatment identifies IL-1beta as a pivotal mediator in Schnitzler syndrome.

Abstract

Extracted data

Related items

Related items